The ABHI Spring Conference: Enabling Regulation

‘Enabling regulation’ is one of the key challenges the ABHI Board of Directors has identified in order to support the future growth of the HealthTech sector. ABHI, along with members and the wider healthcare and regulatory community, continue to lead a programme of work and engagement to guide the developing regulatory strategy for industry in the UK, post-Brexit.

Critical to this is providing a senior industry interface with government and the MHRA, and the creation of thought leadership platforms to capture the insights from leading regulatory figures.

This ABHI conference will drill down into this challenge, addressing three core principles of the strategy: global regulation, access to innovation and future proofing.

A host of experts will be on hand to provide details on the changing regulatory landscape, the key areas impacting businesses and the opportunities for innovators to support the UK’s ambition to put safety and speed-to-market at the centre of its post-Brexit vision.

Confirmed speakers:

• Phil Brown, Director, Regulatory & Compliance, ABHI
• Andrew Davies, Digital Health Lead, ABHI
• Dr Richard Broyd, Advisory Director, Blenheim Chalcot
• Rob Higgins, Senior Regulatory Affairs Manager, MHRA
• Philip Kennedy, Managing Director, Eschmann Technologies & Chair, ABHI
• Dr Michael Kipping, Innovation Lead – Biomedical Catalyst
• Steve Lee, Director, Diagnostics Regulation, ABHI
• Stephen Lightfoot, Chair, MHRA
• Robyn Meurant, Medical Devices and IVD Consultant, NSF
• Johan Ordish, Group Manager, SaMD, MHRA
• Lincoln Tsang, Partner, Ropes & Gray
• Ashley Yeo, Healthcare Editor & Executive Editor Medtech, Informa

View the agenda here.

With thanks to our sponsor: